The effects of pan-lysyl oxidase/lysyl oxidase-like proteins inhibition combined with 5-azacytidine on myeloid neoplasms with bone marrow fibrosis
Saved in:
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1801237654 | ||
| 003 | DE-627 | ||
| 005 | 20230427140257.0 | ||
| 007 | tu | ||
| 008 | 220510s2021 gw ||||| m 00| ||eng c | ||
| 035 | |a (DE-627)1801237654 | ||
| 035 | |a (DE-599)KXP1801237654 | ||
| 035 | |a (OCoLC)1316702446 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-BW | ||
| 082 | 0 | |a 616.027 |q DE-101 | |
| 082 | 0 | 4 | |a 610 |a 570 |q DE-101 |
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Xu, Qingyu |d 1992- |e VerfasserIn |0 (DE-588)1257157019 |0 (DE-627)1801237581 |4 aut | |
| 245 | 1 | 4 | |a The effects of pan-lysyl oxidase/lysyl oxidase-like proteins inhibition combined with 5-azacytidine on myeloid neoplasms with bone marrow fibrosis |c vorgelegt von Qingyu Xu ; Referent: Prof. Dr. med. Daniel Nowak |
| 246 | 3 | 0 | |a oxidase / lysyl |
| 264 | 1 | |a Heidelberg |c 2021 | |
| 300 | |a 111 Blätter |b Diagramme, Illustrationen | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Ruprecht-Karls-Universität Heidelberg |d 2022 | ||
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 700 | 1 | |a Nowak, Daniel |d 1976- |e AkademischeR BetreuerIn |0 (DE-588)131932063 |0 (DE-627)51618041X |0 (DE-576)298844540 |4 dgs | |
| 710 | 2 | |a Universität Heidelberg |e Grad-verleihende Institution |0 (DE-588)2024349-2 |0 (DE-627)102161488 |0 (DE-576)191769517 |4 dgg | |
| 751 | |a Heidelberg |0 (DE-588)4023996-2 |0 (DE-627)106300814 |0 (DE-576)208952578 |4 uvp | ||
| 951 | |a BO | ||
| 992 | |a 20220512 | ||
| 993 | |a Thesis | ||
| 994 | |a 2022 | ||
| 998 | |g 1257157019 |a Xu, Qingyu |m 1257157019:Xu, Qingyu |d 60000 |d 60001 |e 60000PX1257157019 |e 60001PX1257157019 |k 0/60000/ |k 1/60000/60001/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1801237654 |e 4133273974 | ||
| BIB | |a Y | ||
| JSO | |a {"recId":"1801237654","physDesc":[{"noteIll":"Diagramme, Illustrationen","extent":"111 Blätter"}],"name":{"displayForm":["vorgelegt von Qingyu Xu ; Referent: Prof. Dr. med. Daniel Nowak"]},"noteThesis":["Dissertation. - Ruprecht-Karls-Universität Heidelberg. - 2022"],"id":{"eki":["1801237654"]},"person":[{"role":"aut","given":"Qingyu","family":"Xu","display":"Xu, Qingyu"},{"given":"Daniel","role":"dgs","family":"Nowak","display":"Nowak, Daniel"}],"corporate":[{"display":"Universität Heidelberg","role":"dgg"}],"language":["eng"],"type":{"bibl":"thesis"},"origin":[{"publisherPlace":"Heidelberg","dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"title":[{"title_sort":"effects of pan-lysyl oxidase/lysyl oxidase-like proteins inhibition combined with 5-azacytidine on myeloid neoplasms with bone marrow fibrosis","title":"The effects of pan-lysyl oxidase/lysyl oxidase-like proteins inhibition combined with 5-azacytidine on myeloid neoplasms with bone marrow fibrosis"}]} | ||
| SRT | |a XUQINGYUEFFECTSOFP2021 | ||